Chinook Therapeutics, Inc. Employee Directory

Biotechnology ResearchWashington, United States201-500 Employees

We officially combined with Novartis to further strengthen our scientific capabilities and treatments for patients with rare kidney diseases. For more information on the acquisition, see our press release at: https://www.novartis.com/news/media-releases/novartis-completes-acquisition-chinook-therapeutics

See our community guidelines: https://go.novartis.social/3Slt0Up

Find Chinook Therapeutics, Inc. employees' phone numbers or email addresses

Chinook Therapeutics, Inc. Global Highlights

North America
68

United States Of America
61
Canada
7

Europe
1

France
1

Chinook Therapeutics, Inc.'s Leadership

A. G.
Chief Medical Officer
Mobile Phone
Email
T. C.
Senior Executive Assistant To Chief Executive Officer
Mobile Phone
Email
A. D.
Administrative Business Services Partner Ii
Mobile Phone
Email
J. P.
Administrative Business Services Partner
Mobile Phone
Email
N. C.
President
Mobile Phone
Email
R. O.
Vp, Research Operations And Vancouver Site Head
Mobile Phone
Email
D. M.
Executive Director / Head Of Field Medical Affairs
Mobile Phone
Email
B. P.
Medical Director -Field
Mobile Phone
Email

Chinook Therapeutics, Inc. Employee Metrics

100%

50%

2025

2024

Research
Operations
Engineering
Accounting
Program & Project Management
Other
Information Technology
Human Resources
Quality Assurance
Biotechnology
Consultant

Contact profiles from Chinook Therapeutics, Inc.

Name

Title

Contact Info

Location

Last Update

A. E.
Associate Director, Clinical Systems
Mobile Phone
Email
United StatesMississippi
Oct 23, 2024
C. D.
Field Medical Director
Mobile Phone
Email
Oct 23, 2024
J. B.
Director Of Team Programming
Mobile Phone
Email
Oct 17, 2024
J. S.
Executive Director, Special Projects: Chinook Integration Lead
Mobile Phone
Email
Oct 16, 2024
M. L.
Associate Director, Data Management
Mobile Phone
Email
Aug 02, 2023
M. J. A.
Associate Director, Computer Systems Assurance
Mobile Phone
Email
Oct 22, 2024
O. G.
Director Board Of Directors
Mobile Phone
Email
Oct 21, 2024
S. N.
Senior Director, Pharmacology And Translational Biology
Mobile Phone
Email
United StatesConnecticut
Oct 16, 2024
R. K.
Senior Clinical Trial Manager
Mobile Phone
Email
Oct 22, 2024
C. I.
Senior Scientist
Mobile Phone
Email
Oct 22, 2024

Frequently Asked Questions

What is Chinook Therapeutics, Inc. known for?

Chinook Therapeutics, Inc. was founded in 2019 operates in the Biotechnology Research industry. The company's main headquarters is located in Seattle, WA 98102 US. Explore Chinook Therapeutics, Inc.'s company overview page for more information.

What is Chinook Therapeutics, Inc.'s most common email format?

Chinook Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Chinook Therapeutics, Inc. email formats with LeadIQ.

How many employees does Chinook Therapeutics, Inc. have currently?

Chinook Therapeutics, Inc. has approximately 201 employees as of September 2025. These team members are located across 2 continents, including North AmericaEurope.

Who are Chinook Therapeutics, Inc.'s key employees and leadership?

As of September 2025, Chinook Therapeutics, Inc.'s key employees include:

Chief Medical Officer: A. G.
Senior Executive Assistant To Chief Executive Officer: T. C.
Administrative Business Services Partner Ii: A. D.
Administrative Business Services Partner: J. P.
President: N. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.